GlassScriptPhysician profile
Jaspreet Kaur
NPI 1487485298
$2,283.24
in general payments reported to CMS, 2019-2025
18 companies · $2,021 in 2025
The $2,021 reported for 2025 was more than what 94% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $262 · 2025: $2,021.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,283.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,283.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $656.00 | 2025 | |
| Ucb, INC. | $406.81 | 2024-2025 | Nayzilam, Rystiggo, Fintepla |
| Lundbeck LLC | $309.60 | 2024-2025 | Vyepti |
| Merz Pharmaceuticals, LLC | $211.50 | 2024-2025 | Xeomin, Inbrija, Ampyra |
| Novartis Pharmaceuticals Corporation | $159.96 | 2025 | |
| Genentech USA, INC. | $80.96 | 2025 | Ocrevus Zunovo, Ocrevus |
| Sk Life Science, INC. | $70.41 | 2025 | |
| Eisai INC. | $63.68 | 2024-2025 | |
| Pfizer INC. | $60.26 | 2025 | |
| W. L. Gore & Associates, INC. | $59.46 | 2025 | Gore Viabahn Vbx Balloon Expandable Endo |
| Jazz Pharmaceuticals INC. | $49.90 | 2025 | |
| Neurelis, INC. | $26.81 | 2025 | Valtoco |
| Astrazeneca Pharmaceuticals LP | $26.30 | 2025 | Wainua |
| Octapharma USA, INC. | $25.30 | 2025 | Panzyga |
| Catalyst Pharmaceuticals, INC. | $24.65 | 2024 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech, INC. | $18.56 | 2025 | Itovebi |
| Axsome Therapeutics, INC. | $17.27 | 2025 | Symbravo |
| Livanova USA, INC. | $15.81 | 2024 | Vns Therapy Sentiva Model 1000 Generator |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jaspreet Kaur listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.